Specifically, CYP1A1 is a monooxygenase that catalyzes the production of reactive metabolites of tobacco smoke components and was highly induced, i.e., > 24-fold and > eightfold, respectively, in mice and female LC patients (Supplementary Table S9). The gene discussed is CYP1A1; the disease is laryngotracheoesophageal cleft.